Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The proto-oncogene Bcl3 induces immune checkpoint PD-L1 expression, mediating proliferation of ovarian cancer cells
Yue Zou, Mohammad M. Uddin, Sveta Padmanabhan, et al.
Journal of Biological Chemistry (2018) Vol. 293, Iss. 40, pp. 15483-15496
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Targeting the NF-κB pathway as a potential regulator of immune checkpoints in cancer immunotherapy
Nasim Ebrahimi, Al‐Hasnawi Rasool Riyadh Abdulwahid, Atena Mansouri, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 29
NF-κB and Its Role in Checkpoint Control
Annika Betzler, Marie‐Nicole Theodoraki, Patrick J. Schuler, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3949-3949
Open Access | Times Cited: 74
NF-κB role on tumor proliferation, migration, invasion and immune escape
Afrasyab Khan, Yao Zhang, Ningna Ma, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 11, pp. 1599-1610
Closed Access | Times Cited: 13
Multifaceted roles for BCL3 in cancer: a proto-oncogene comes of age
Gillian Seaton, Hannah Smith, Andrea Brancale, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10
MiR-34a-5p/PD-L1 axis regulates cisplatin chemoresistance of ovarian cancer cells
Ying Zuo, Wenwen Zheng, J. Liu, et al.
Neoplasma (2019) Vol. 67, Iss. 01, pp. 93-101
Open Access | Times Cited: 67
Codelivery of STAT3 and PD-L1 siRNA by hyaluronate-TAT trimethyl/thiolated chitosan nanoparticles suppresses cancer progression in tumor-bearing mice
Shima Bastaki, A. Surendar, Nasrin Ahmadpour Saheb, et al.
Life Sciences (2020) Vol. 266, pp. 118847-118847
Closed Access | Times Cited: 66
Inhibitory Effect of Hesperidin on the Expression of Programmed Death Ligand (PD-L1) in Breast Cancer
Prachya Kongtawelert, Benjawan Wudtiwai, Thuzar Hla Shwe, et al.
Molecules (2020) Vol. 25, Iss. 2, pp. 252-252
Open Access | Times Cited: 64
NF-κB Signaling in Tumor Pathways Focusing on Breast and Ovarian Cancer
Monika Devanaboyina, Jasskiran Kaur, Emma Whiteley, et al.
Oncology Reviews (2022) Vol. 16
Open Access | Times Cited: 38
M2 macrophages promote PD-L1 expression in triple-negative breast cancer via secreting CXCL1
Lifen Zhang, Shanzhi Gu, Lu Wang, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155458-155458
Open Access | Times Cited: 7
EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer
Alexander Ring, Pushpinder Kaur, Julie E. Lang
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 45
IFNγ-induced PD-L1 expression in ovarian cancer cells is regulated by JAK1, STAT1 and IRF1 signaling
Sveta Padmanabhan, Bijaya Gaire, Yue Zou, et al.
Cellular Signalling (2022) Vol. 97, pp. 110400-110400
Open Access | Times Cited: 23
Different Shades of L1CAM in the Pathophysiology of Cancer Stem Cells
Marco Giordano, Ugo Cavallaro
Journal of Clinical Medicine (2020) Vol. 9, Iss. 5, pp. 1502-1502
Open Access | Times Cited: 39
Triptolide suppresses oral cancer cell PD-L1 expression in the interferon-γ-modulated microenvironment in vitro, in vivo, and in clinical patients
Chin‐Shan Kuo, Cheng‐Yu Yang, Chih‐Kung Lin, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 111057-111057
Open Access | Times Cited: 35
Activated heme synthesis regulates glycolysis and oxidative metabolism in breast and ovarian cancer cells
Pritpal Kaur, Shreya Nagar, Madhura Bhagwat, et al.
PLoS ONE (2021) Vol. 16, Iss. 11, pp. e0260400-e0260400
Open Access | Times Cited: 32
Discovery of a small molecule that inhibits Bcl-3-mediated cyclin D1 expression in melanoma cells
Karunakar Saamarthy, Kristofer Ahlqvist, Renée Daams, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
An optimised Bcl‐3 inhibitor for melanoma treatment
Karunakar Saamarthy, Renée Daams, Wondossen Sime, et al.
British Journal of Pharmacology (2025)
Open Access
The role of B-Cell Lymphoma-3 (BCL-3) in enabling the hallmarks of cancer: implications for the treatment of colorectal carcinogenesis
Danny Legge, A Chambers, Christopher Parker, et al.
Carcinogenesis (2020) Vol. 41, Iss. 3, pp. 249-256
Open Access | Times Cited: 32
Polyphenols Modulating Effects of PD-L1/PD-1 Checkpoint and EMT-Mediated PD-L1 Overexpression in Breast Cancer
Samia S. Messeha, Najla O. Zarmouh, Karam F. A. Soliman
Nutrients (2021) Vol. 13, Iss. 5, pp. 1718-1718
Open Access | Times Cited: 26
Immune checkpoint protein PD-L1 promotes transcription of angiogenic and oncogenic proteins IL-8, Bcl3 and STAT1 in ovarian cancer cells
Suprataptha U. Reddy, Rachel Sham, Karin Enell Smith, et al.
Journal of Biological Chemistry (2025), pp. 108339-108339
Open Access
Knockdown of long non‐coding RNA LINC00176 suppresses ovarian cancer progression by BCL3‐mediated down‐regulation of ceruloplasmin
Lan Dai, Jixiang Niu, Yanli Feng
Journal of Cellular and Molecular Medicine (2019) Vol. 24, Iss. 1, pp. 202-213
Open Access | Times Cited: 28
Salmonella Breaks Tumor Immune Tolerance by Downregulating Tumor Programmed Death-Ligand 1 Expression
Man‐Chin Chen, Christian R. Pangilinan, Che‐Hsin Lee
Cancers (2019) Vol. 12, Iss. 1, pp. 57-57
Open Access | Times Cited: 28
DNA methylation landscape of tumor‐associated macrophages reveals pathways, transcription factors and prognostic value relevant to triple‐negative breast cancer patients
Joschka Hey, Coral Halperin, Mark Hartmann, et al.
International Journal of Cancer (2022) Vol. 152, Iss. 6, pp. 1226-1242
Open Access | Times Cited: 15
IκB kinase‐α coordinates BRD4 and JAK/STAT signaling to subvert DNA damage‐based anticancer therapy
Irene Pecharromán, Laura Solé, Daniel Álvarez‐Villanueva, et al.
The EMBO Journal (2023) Vol. 42, Iss. 21
Open Access | Times Cited: 9
IFNγ-Induced Bcl3, PD-L1 and IL-8 Signaling in Ovarian Cancer: Mechanisms and Clinical Significance
Suprataptha U. Reddy, Fatema Zohra Sadia, Aleš Vančura, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2676-2676
Open Access | Times Cited: 2
The Perfect Combination: Enhancing Patient Response to PD-1-Based Therapies in Epithelial Ovarian Cancer
Nicole James, Morgan Woodman, Paul DiSilvestro, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2150-2150
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top